Top Markets
Coin of the day
Advanced Proteome Therapeutics Corporation Advanced Proteome Therapeutics Corporation

Advanced Proteome Therapeutics Corporation

APTCF
Classement en actions #40426
Advanced Proteome Therapeutics Corporation, operating through its subsidiary... Advanced Proteome Therapeutics Corporation, operating through its subsidiary Advanced Proteome Therapeutics Inc., functions as a biotechnology company based in the United States. Its core business involves the creation and commercialization of a unique platform designed for the chemical modification of protein-based treatments. This proprietary technology is applied across several domains, specifically antibody-drug conjugates, broader protein conjugates, and approaches to immunomodulation. The company's corporate base is in Burnaby, Canada.
Prix de l'action
$0.0002
Dernière synchronisation: 2025-05-15
Capitalisation boursière
$149.63K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
CA
Échange Advanced Proteome Therapeutics Corporation (APTCF)

Catégorie

Ratio P/B pour Advanced Proteome Therapeutics Corporation (APTCF)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Advanced Proteome Therapeutics Corporation, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Advanced Proteome Therapeutics Corporation de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE